Skip to main content

Simon Baker

x
Simon Baker

Simon is a Partner of Redburn and a member of the Healthcare research team. He specialises in pharma and biotech and has covered those sectors for over 21 years. His recent work includes an evaluation of the opportunity for gene therapy (Feb 2021, 2,148 pages) featuring a proprietary scoring framework for around 4,000 diseases and an analysis of the IP landscape of US biologic drugs since 2000 (October 2021, 194 pages). Prior to joining Redburn, Simon co-headed pharmaceutical research at Exane BNP Paribas, having previously followed the sector at Occitan Capital, Credit Suisse and Lehman Brothers.

Contact Simon Baker | Back to Analysts